In the US, Catapres-TTS (clonidine systemic) is a member of the drug class antiadrenergic agents, centrally acting and is used to treat Alcohol Withdrawal, Anxiety, Benzodiazepine Withdrawal, Bipolar Disorder, High Blood Pressure, Migraine Prevention, Opiate Withdrawal, Perimenopausal Symptoms and Smoking Cessation.
US matches:
- Catapres-TTS Patches
- Catapres-TTS-1 transdermal
- Catapres-TTS-2 transdermal
- Catapres-TTS-3 transdermal
- Catapres-TTS-1
- Catapres-TTS-2
- Catapres-TTS-3
- Catapres-TTS
Ingredient matches for Catapres-TTS
Clonidine
Clonidine is reported as an ingredient of Catapres-TTS in the following countries:
- United States
Clonidine hydrochloride (a derivative of Clonidine) is reported as an ingredient of Catapres-TTS in the following countries:
- New Zealand
International Drug Name Search
No comments:
Post a Comment